Abstract
The aim of this study is to investigate whether melittin and apamin exhibit any effect on human hepatic cells (L02 cells) and hepatocellular carcinoma cells (HepG2) growth through apoptosis. The results did not show any cytotoxic effect on the L02 cells but did show a synergistic effect of apamin on liver injury. Moreover, melittin and apamin could inhibit the growth of HepG2 cells in a dose-/time-dependent manner and initiate markedly early apoptosis of HepG2 cells. The results of this study showed melittin and apamin have potential as new therapy of liver cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
